Product Information
ERYTHROMYCIN 250 MG TABLET is a generic product labeled by Arbor Pharmaceuticals, Inc., priced at $1.9028 per EA under NDC 24338010213. Its NADAC has been published 599 times since Nov 28, 2013.
Strength
250 mg/1
Manufacturer
Arbor Pharmaceuticals, Inc.NDC
24338010213
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
4/23/2025
Active Ingredients
ERYTHROMYCINApproval Type
Generic (ANDA)
FDA Application
ANDA061621On Market Since
9/6/2011
Pharmacological Classes
Price Statistics
The NADAC for ERYTHROMYCIN 250 MG TABLET has been published 599 times since Nov 28, 2013, and over the history we have for it it has declined 30.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.9028 per EA |
|---|---|
| All-time high | $11.1376 (Mar 14, 2018) |
| All-time low | $1.3349 (May 22, 2024) |
| Median price | $8.6203 |
| Average price | $7.4007 |
| Largest weekly change | -54.7% (Apr 17, 2024) |
| Weeks tracked | 599 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ERYTHROMYCIN 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ERYTHROMYCIN 250 MG TABLET, manufactured by Arbor Pharmaceuticals, Inc., is $1.9028 per EA (NDC 24338010213), effective May 14, 2025.
How has the price of ERYTHROMYCIN 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for ERYTHROMYCIN 250 MG TABLET has declined 30.5%. It has been tracked across 599 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ERYTHROMYCIN 250 MG TABLET?
Since Nov 28, 2013, the NADAC for ERYTHROMYCIN 250 MG TABLET has ranged from a low of $1.3349 (May 22, 2024) to a high of $11.1376 (Mar 14, 2018), with a median of $8.6203 per EA.
Are there cheaper alternatives to ERYTHROMYCIN 250 MG TABLET?
Yes. 6 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, ERYTHROMYCIN 250 MG TABLET, is $1.7409 per EA — about 9% below ERYTHROMYCIN 250 MG TABLET.
Who manufactures ERYTHROMYCIN 250 MG TABLET?
ERYTHROMYCIN 250 MG TABLET (NDC 24338010213) is labeled by Arbor Pharmaceuticals, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification